問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

黃金安、周政達、黃彥翔、梁巧盈
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2020-07-15 - 2026-07-31

Phase IV

Active
A 12-month, Prospective, Multi-center Post-authorization Commitment (PAC) Study Monitoring Safety in Adult Patients With Relapsing-remitting Multiple Sclerosis Newly Initiated on Gilenya (Fingolimod) in Taiwan (SPRING)
  • Condition/Disease

    Multiple Sclerosis

  • Test Drug

    Gilenya hard Capsules 0.5mg

Participate Sites
6Sites

Not yet recruiting3Sites

Recruiting3Sites